Literature DB >> 30610592

An Introduction to LFA-1/ICAM-1 Interactions in T-Cell Motility.

Navin Kumar Verma1, Dermot Kelleher2,3.   

Abstract

The inherent ability of T-cells to migrate is critical for a fully functional immune system, both in normal immune surveillance and for mounting an adaptive immune response. At the same time, inappropriate trafficking of T-cells can be a pathological factor for immune-mediated or chronic inflammatory diseases. T-cell motility is critically dependent on a series of ligand-receptor interactions, a precisely regulated intracellular signaling, an involvement of adaptor proteins, and dynamic remodeling of the cytoskeletal systems. The leukocyte integrin LFA-1 receptor present on T-cells binds to the ligand intercellular adhesion molecule 1 (ICAM-1) and this LFA-1/ICAM-1 contact acts as a trigger for T-cell motility. In this book, we present a collection of methods and protocols that are frequently used by researchers to better understand T-cell motility in health and diseases.

Entities:  

Keywords:  Autoimmunity; Inflammation; Integrin; Signal transduction; T-cell contact

Mesh:

Substances:

Year:  2019        PMID: 30610592     DOI: 10.1007/978-1-4939-9036-8_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  IL-27 shapes the immune properties of human astrocytes and their impact on encountered human T lymphocytes.

Authors:  Florent Lemaître; Negar Farzam-Kia; Ana Carmena Moratalla; Yves Carpentier Solorio; Marie-Laure Clenet; Olivier Tastet; Aurélie Cleret-Buhot; Jean Victor Guimond; Elie Haddad; Pierre Duquette; J Marc Girard; Alexandre Prat; Catherine Larochelle; Nathalie Arbour
Journal:  J Neuroinflammation       Date:  2022-09-01       Impact factor: 9.587

2.  Blocking LFA-1 Aggravates Cardiac Inflammation in Experimental Autoimmune Myocarditis.

Authors:  Ludwig T Weckbach; Andreas Uhl; Felicitas Boehm; Valentina Seitelberger; Bruno C Huber; Gabriela Kania; Stefan Brunner; Ulrich Grabmaier
Journal:  Cells       Date:  2019-10-17       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.